Skip to content
OL

Updated:

Octave Life Sciences

Octave Life Sciences invests in healthcare, life sciences, and pharmaceutical companies. The firm supports businesses developing medical treatments,...

Overview

Octave Life Sciences invests in healthcare, life sciences, and pharmaceutical companies. The firm supports businesses developing medical treatments, biotechnology, and related technologies, providing capital across different stages of growth. It is based in Miami, Florida.

General information

Year founded

2018

Location

Region

Asia

Country

India

City

Mumbai

Corporate office

Mumbai, India

Sector focus

Healthcare ServicesPharmaceuticals

Frequently asked questions

Who owns Octave Life Sciences?

Ownership of Octave Life Sciences is not publicly disclosed. The firm's website lists no principals or shareholders. Without a public register or credible third-party source, ownership information remains unavailable.

Does Octave Life Sciences invest in other companies?

There is no public evidence that Octave Life Sciences engages in venture capital, private equity, or any form of external investment. The company's website describes it as a marketer of pharmaceutical products, not an investment vehicle.

What products does Octave Life Sciences sell?

Octave Life Sciences markets over 15 pharmaceutical products in forms including tablets (Pencifast-625, Immunfast, Pidimol-650), capsules (Ocikill, Itave-200, Ostave), injections (Pidimol AQ, Panrium-40, Tazodac, Pidisunate), syrups (Hepamate, Silenser-D, Fast-D3), and an ointment (Dermisytic). Many are generic versions of antibiotics, analgesics, and nutritional supplements (per the firm's website).

Where does Octave Life Sciences operate geographically?

The firm is headquartered in Mumbai, India, and markets products domestically as well as to export markets. Specific export countries are not named on the company's website.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles